APGYX | RGACX | APGYX / RGACX | |
Total Expense Ratio | 0.57 | 0.94 | 61% |
Annual Report Gross Expense Ratio | 0.58 | 0.94 | 62% |
Fund Existence | 29 years | 23 years | - |
Gain YTD | 10.842 | 14.044 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.8B | 329B | 8% |
Annual Yield % from dividends | 0.05 | 0.07 | 70% |
Returns for 1 year | 11.54 | 14.08 | 82% |
Returns for 3 years | 49.04 | 41.19 | 119% |
Returns for 5 years | 60.00 | 41.95 | 143% |
Returns for 10 years | 177.50 | 83.68 | 212% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 138.76 | 1.49 | +1.09% |
iShares Biotechnology ETF | |||
SCHJ | 24.84 | 0.01 | +0.04% |
Schwab 1-5 Year Corporate Bond ETF | |||
BUFS | 21.67 | -0.02 | -0.09% |
FT Vest Laddered Small Cap Moderate Buffer ETF | |||
JANZ | 36.78 | -0.13 | -0.37% |
TrueShares Structured Outcome JanuaryETF | |||
MSFO | 18.10 | -0.08 | -0.44% |
YieldMax MSFT Option Income Strategy ETF |